Astellas Aims To Block Generic In Incontinence Drug IP Fight
A Japanese pharma giant has fought back against litigation brought by Sandoz seeking to revoke its patent for treating urinary problems, asking the English courts for an injunction to block the...To view the full article, register now.
Already a subscriber? Click here to view full article